Moua Yang, Ph.D.

Dr. Yang’s primary research is understanding the redox mechanisms that promote thrombosis. Specifically, his interest is in oxidative cysteine modification and how they participate in the thrombotic machinery. In this context the Yang laboratory employs a technical tour-de-force of chemical biology, protein biochemistry, and real-time intravital imaging to unravel the mechanisms.

Dr. Yang also investigates a family of enzymes called thiol isomerases that function to make and break disulfides during protein folding. These enzymes escape into the blood stream and play a critical role in clot formation. The Yang laboratory seeks to understand the mechanisms of how thiol isomerases promote thrombus formation in oxidative stress.

Areas of Study

• Mechanisms of thiol isomerases in thrombosis, hemostasis, and microvascular occlusion
• Natural compounds as anti-thrombotics

Dr. Yang’s Background

• Joined Bloodworks Northwest in 2024
• 2022-2024: Instructor, Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School
• 2019-2022: Postdoctoral Research Fellow, Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center.
• 2018-2019: Postdoctoral Research Fellow, Department of Biochemistry, Medical College of Wisconsin

Moua Yang, Ph.D.

Assistant Member
Bloodworks Northwest Research Institute

Bloodworks Northwest
Research Institute
1551 Eastlake Avenue E, Suite 100
Seattle, WA 98104

Email: [email protected]
Phone: (206) 689-6285